VISCONTI, ROBERTA
 Distribuzione geografica
Continente #
AS - Asia 2.263
NA - Nord America 2.089
EU - Europa 1.375
SA - Sud America 275
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 65
OC - Oceania 4
Totale 6.177
Nazione #
US - Stati Uniti d'America 1.980
SG - Singapore 945
RU - Federazione Russa 594
VN - Vietnam 482
CN - Cina 440
IT - Italia 341
BR - Brasile 204
HK - Hong Kong 154
CA - Canada 70
FR - Francia 70
DE - Germania 63
NL - Olanda 62
GB - Regno Unito 47
FI - Finlandia 43
JP - Giappone 43
UA - Ucraina 43
BD - Bangladesh 41
IE - Irlanda 40
IN - India 39
AR - Argentina 27
KR - Corea 26
CI - Costa d'Avorio 20
MX - Messico 19
ZA - Sudafrica 18
PL - Polonia 17
ES - Italia 15
IQ - Iraq 13
PH - Filippine 13
EC - Ecuador 12
TH - Thailandia 12
AT - Austria 10
CO - Colombia 9
PK - Pakistan 9
VE - Venezuela 9
ID - Indonesia 8
BE - Belgio 7
SE - Svezia 7
JM - Giamaica 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
TR - Turchia 5
PE - Perù 4
TN - Tunisia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
UY - Uruguay 3
AU - Australia 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
SN - Senegal 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 6.071
Città #
Singapore 452
San Jose 346
Ashburn 170
Hong Kong 144
Moscow 141
Ho Chi Minh City 128
Chandler 116
Hanoi 116
Beijing 101
Council Bluffs 96
Hefei 91
Santa Clara 89
Naples 82
Napoli 81
Los Angeles 70
The Dalles 60
Amsterdam 50
Lauterbourg 50
Jacksonville 43
Tokyo 39
Millbury 37
Princeton 34
Nanjing 28
New York 28
Haiphong 27
Buffalo 24
Seoul 24
Boston 22
Dong Ket 21
Montreal 20
São Paulo 20
Munich 19
Da Nang 18
Dallas 18
Ottawa 18
Toronto 17
Wilmington 17
Frankfurt am Main 16
Phoenix 16
Redondo Beach 16
Seattle 15
Brooklyn 14
Orem 14
Mexico City 13
Chicago 12
Des Moines 12
Ann Arbor 11
Johannesburg 11
Milan 11
Rome 11
Woodbridge 11
Atlanta 10
Warsaw 10
Can Tho 8
Chennai 8
Denver 8
London 8
Nuremberg 8
Poplar 8
Shenyang 8
Tianjin 8
Nanchang 7
Pozzuoli 7
San Giovanni Rotondo 7
Thái Nguyên 7
Guayaquil 6
Lawrence 6
Nha Trang 6
Porto Alegre 6
Thái Bình 6
Wroclaw 6
Baghdad 5
Bangkok 5
Curitiba 5
Formia 5
Goiânia 5
Houston 5
Jiaxing 5
Kochi 5
Lahore 5
Phủ Lý 5
Rio de Janeiro 5
Verona 5
Belo Horizonte 4
Biên Hòa 4
Bogotá 4
Buenos Aires 4
Changsha 4
Dublin 4
Falls Church 4
General Trias 4
Hải Dương 4
Lappeenranta 4
Ninh Bình 4
Quận Ba 4
Stockholm 4
Tampa 4
Turku 4
Vienna 4
Washington 4
Totale 3.316
Nome #
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth 185
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 166
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 166
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms [*Della Monica, R. e Cuomo, M. co-primi autori] 161
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? 160
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance 153
A Rare Adult Primary Intracranial Sarcoma, DICER1-Mutant Identified by Epigenomic Profiling: A Case Report [*Marinelli A., Cuomo M. co-primi autori] 151
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 149
Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1 145
Molecular biology of the MEN2 gene 142
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 139
Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues [*Cuomo, M co-corresponding] 139
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS. 137
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword 137
Wee1 rather than plk1 is inhibited by AZD1775 at therapeutically relevant concentrations 137
ATM controls proper mitotic spindle structure 134
Different mutations of the RET gene cause different human tumoral diseases. 132
Host fecal DNA specific methylation signatures mark gut dysbiosis and inflammation in children affected by autism spectrum disorder 131
Requirement for proteolysis in spindle assembly checkpoint silencing. 128
Fighting tubulin-targeting anticancer drug toxicity and resistance 128
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma 128
The end of mitosis from a phosphatase perspective 127
Ret-mediated mitogenesis requires Src kinase activity. 125
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept 125
MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme 124
The platelet derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. 117
Sustaining the Spindle Assembly Checkpoint to improve cancer therapy 117
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 112
Akt/PKB promotes survival and hormone-independent proliferation of thyroid cells in the absence of de-differentiated and transforming effects. 106
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 106
Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression 106
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. 105
New insights on oxidative stress in cancer. 97
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 93
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment 87
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 84
DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivo 83
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. 79
Fcp1-dependent dephosphorylation is requiredfor M-phase-promoting factor inactivation at mitosis exit 77
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 76
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment 75
New therapeutic perspectives in CCDC6 deficient lung cancer cells. 74
Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas. 72
A specific pluripotency-associated eRNA controls Nanog locus by shaping the epigenetic landscape and stabilizing enhancer–promoter interaction 69
Multiple functions of the lysine methyltransferase KMT5a in cancer: potential targets for innovative therapies (R. VISCONTI LAST AND CORRESPONDING AUTHOR) 69
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 65
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer 58
The Expression of the High-mobility Group Hmgi (y) Proteins Correlates With the Malignant Phenotype of Human Thyroid Neoplasias 58
Ret/ptc Oncogene Activation Is An Early Event In Thyroid Carcinogenesis 56
Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity 51
High level expression of the HMGI (Y) gene during embryonic development. 51
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 48
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 47
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC 47
Type I IFNs and regulation of TH I responses: Enigmas both resolved and emerge 39
Characterization and analysis of the proximal Janus kinase 3 promoter 33
Signaling by Type I and II cytokine receptors: Ten years after 32
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α 32
STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation 32
Jaks and Stats as therapeutic targets 31
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation 29
The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ chain-using cytokines 27
The between now and then of lung cancer chemotherapy and immunotherapy 26
The lysine methyltransferase KMT5a and p53 regulate the expression of the key autophagy adaptor p62/SQSTM1 in glioblastoma 23
Molecular aspects of primary immunodeficiencies: Lessons from cytokine and other signaling pathways 21
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 18
Totale 6.177
Categoria #
all - tutte 20.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022224 0 0 0 7 0 7 3 5 40 8 74 80
2022/2023312 43 30 1 24 25 30 1 27 43 52 30 6
2023/2024232 11 37 26 27 20 6 9 36 3 2 41 14
2024/20251.308 72 79 5 9 43 67 143 77 84 129 483 117
2025/20263.404 281 187 368 426 615 139 361 187 433 247 88 72
2026/2027196 77 117 2 0 0 0 0 0 0 0 0 0
Totale 6.177